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The glutamine commute: take the N line 
and transfer to the A
 
Farrukh A. Chaudhry, Richard J. Reimer, and Robert H. Edwards
 
Graduate Programs in Neuroscience, Cell Biology, and Biomedical Sciences, Departments of Neurology and Physiology, 
University of California at San Francisco School of Medicine, San Francisco, CA 94143
 
The transfer of glutamine between cells contributes to
signaling as well as to metabolism. The recent identification
and characterization of the system N and A family of
transporters has begun to suggest mechanisms for the
directional transfer of glutamine, and should provide ways
to test its physiological significance in diverse processes
from nitrogen to neurotransmitter release.
 
In multicellular organisms, the diverse function of specialized
tissues requires mechanisms to coordinate their activity.
This generally involves signaling between cells. In many
cases, a soluble signal released by one cell activates the recep-
tor in a second cell. In other cases, the signal involves contact
with extracellular matrix rather than a soluble mediator or
direct contact between cells in the case of adhesion molecules.
In addition, many tissues interact through an entirely distinct
mechanism—the transfer of metabolic intermediates. In this
case, release often involves transport across the plasma mem-
brane rather than exocytosis and the response uptake rather
than activation of a cell surface receptor. The transferred
substance has direct effects on cell function and may not
require second messengers. The molecular basis and physio-
logical role of many such transfer reactions remain poorly
understood relative to other forms of signaling. In this review,
we focus on the transfer between cells of the amino acid
glutamine. Although involved in metabolism, glutamine
transfer also participates in signal transduction.
 
Glutamine transfer between cells
 
Glutamine contributes to many metabolic pathways. The
biosynthesis of other amino acids, proteins, nucleotides, and
amino sugars all requires glutamine. Rapidly dividing cells
such as in the gut and hair prefer glutamine as a carbon
source for growth. The standard growth of cultured cells in
high (5 mM) concentrations of glutamine attests to its
importance. In vivo, skeletal muscle produces glutamine
(through the action of glutamine synthetase) for consumption
as a source of energy by several other tissues including the
gut (Kvamme, 1988). Indeed, glutamine is the most
abundant amino acid in blood, contributing one fifth of
the total amino acid. These high levels presumably reflect
the importance of glutamine transfer from producing to
consuming tissues.
Glutamine also participates in more specialized metabolic
pathways. In the kidney, the ammonia produced from
conversion of glutamine to glutamate (by the enzyme
glutaminase) promotes acid excretion (Bender, 1975). In the
liver, glutamine has a central role in nitrogen metabolism.
Together with the ammonia derived from portal blood, the
ammonia produced by glutaminase helps to drive the urea
cycle. Excess ammonia not converted into urea is then in-
corporated into glutamine through the action of glutamine
synthetase. However, glutaminase and the urea cycle enzyme
activities reside in a distinct set of hepatocytes from glutamine
synthetase (Haussinger, 1990). Periportal hepatocytes, the
vast majority of cells in the liver, express glutaminase. In
contrast, the less abundant perivenous hepatocytes express-
ing glutamine synthetase occur downstream in the vascular
system in good position to scavenge the ammonia not
consumed by periportal cells. The liver thus exhibits a
glutamine–glutamate cycle in which periportal cells convert
glutamine to glutamate (and ammonia) and perivenous cells
transform glutamate into glutamine (Fig. 1 A). The brain
exhibits a similar glutamine–glutamate cycle but for an
entirely different purpose than nitrogen metabolism.
Synaptic transmission involves the regulated release of
neurotransmitter by exocytosis. Since neurosecretory vesicles
contain large amounts of transmitter (up to molar concen-
trations in certain cases), the high rates of firing observed at
many synapses require mechanisms to replenish the depleted
stores. Most classical transmitters are taken back up directly
into the nerve terminal. Indeed, disruption of the gene respon-
sible for dopamine reuptake results in depletion of dopamine
stores despite increased extracellular levels (Giros et al., 1996).
However, transporters for the principal excitatory transmitter
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glutamate reside primarily on astrocytes, and those expressed
by neurons are, with certain exceptions (Gundersen et al.,
1996; Arriza et al., 1997), generally postsynaptic (Rothstein
et al., 1994; Dehnes et al., 1998). Glutamate thus requires an
alternative mechanism for recycling. After release from the
nerve terminal, glutamate accumulates in astrocytes through
the action of known glutamate transporters (Fig. 1 B). Gluta-
mine synthetase in astrocytes then converts glutamate to glu-
tamine (Rothstein and Tabakoff, 1984). After transfer back
to neurons, the glutaminase expressed by excitatory neurons
converts glutamine to glutamate before repackaging into vesi-
cles. Supporting this mechanism, the bulk of glutamate re-
leased as transmitter derives from glutamine (Hamberger et
al., 1979; Thanki et al., 1983), and the inhibition of gluta-
minase depletes glutamate stores (Conti and Minelli, 1994).
Exogenous glutamine can also maintain synaptic activity in
the absence of glutamine synthetase activity (Barnett et al.,
2000). Since 
 

 
–aminoisobutyric acid (GABA) derives from
glutamate, the glutamine–glutamate cycle may contribute to
inhibitory and excitatory neurotransmission (Pow and Robin-
son, 1994; Laake et al., 1995). Further, the cerebrospinal
fluid contains 
 

 
0.5 mM glutamine, whereas no other amino
acid exceeds 50 
 

 
M (McGale et al., 1977), indicating the im-
portance of glutamine transfer in the brain. However, despite
investigation over several decades the mechanisms involved in
glutamine transfer and the actual role of the glutamine–
glutamate cycle in the regulation of amino acid release have
remained uncertain.
Classical studies have identified multiple distinct activities
that transport glutamine across the plasma membrane of
mammalian cells. Christensen and colleagues originally
demonstrated the existence of two independent neutral
amino acid uptake activities that they referred to as systems
L and A (Oxender and Christensen, 1963). System L has a
preference for leucine but also recognizes neutral amino ac-
ids including glutamine. Recent work has shown that system
L is a heterodimer composed of the 4F2 heavy chain and a
light chain, either the ubiquitously expressed broad specific-
ity LAT1 or LAT2, which is expressed at the basolateral sur-
face of epithelia (Verrey et al., 2000; Chillaron et al., 2001;
Wagner et al., 2001). Although widespread, system L activ-
ity contributes relatively little to glutamine transport by
most cells. In addition, system L is Na
 

 
 independent and
does not appear to mediate net amino acid flux. Rather, it
acts principally to exchange extracellular for cytoplasmic
amino acid and hence relies on other active transporters for
the cytoplasmic store of amino acid that can be exchanged.
In contrast to system L, system A depends on Na
 

 
 and
can actively transport amino acids against a concentration
gradient. Therefore, it contributes to the cytoplasmic amino
acid exchanged by system L. System A has a preference for
alanine but also recognizes neutral amino acids with short,
polar, or linear side chains, including glutamine, and shows
particular sensitivity to inhibition by low pH. Unlike many
other amino acid transport systems, system A recognizes
 
N
 
-methylated amino acids. In addition, system A is highly
regulated (McGivan and Pastor-Anglada, 1994). Extracellu-
lar amino acid concentrations, hormones, the cell cycle, and
osmolarity control system A activity through a combination
of short and long term mechanisms. Association with the cy-
toskeleton may account for several of these properties (Han-
dlogten et al., 1996). Despite its general importance and
interesting regulation, system A has eluded molecular char-
acterization (Palacin et al., 1998) until recently.
In the liver, glutamine uptake depends on Na
 

 
 but ex-
hibits a component resistant to inhibition by 
 
N
 
-methy-
lated amino acids, distinct from system A. This activity
has the highest affinity for glutamine, followed by histi-
dine and asparagine, and was designated system N (Kil-
berg et al., 1980). Although not initially detected in other
tissues, related activities were subsequently described in
muscle (Nm) and brain (Nb) (Hundal et al., 1987; Tama-
rappoo et al., 1997). Interestingly, system N resembles sys-
tem A in its sensitivity to low pH and regulation by os-
molarity (Bode and Kilberg, 1991). It has also eluded
molecular analysis. Several other proteins transport glu-
tamine as well, including the system ASC exchanger
ASCT2, which belongs to the family of EAATs (Ut-
Figure 1. The glutamine–glutamate 
cycles in the liver and nervous system. 
(A) In periportal cells (top) of the liver, 
glutaminase (glnase) converts glutamine 
to glutamate and ammonia. Along with 
the ammonia directly supplied from the 
portal circulation, the ammonia derived 
from glutamine feeds into the urea cycle. 
The glutamine synthetase (gs) in 
perivenous cells (bottom) converts the 
ammonia that escapes the urea cycle 
into glutamine. (B) In the nervous 
system, the glutamate released by 
exocytosis from nerve terminals is taken 
up by astrocytes through known excitatory 
amino acid transporters and converted 
to glutamine by glutamine synthetase. 
Glutamine is then transferred from 
astrocytes to neurons and converted 
back to glutamate by glutaminase before 
packaging into vesicles.
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sunomiya-Tate et al., 1996) and the system B
 
0,
 

 
 trans-
porter ATB
 
0,
 

 
 (Sloan and Mager, 1999). Despite many at-
tempts at biochemical purification and expression cloning,
the first protein responsible for system N activity was
identified through the analysis of an orphan transporter.
 
System N mediates efflux
 
Classical neurotransmitters are synthesized in the cytoplasm
and require uptake by secretory vesicles for exocytotic re-
lease. In general, vesicular transport depends on an H
 

 
 elec-
trochemical gradient across the vesicle membrane generated
by the vacuolar H
 

 
-ATPase (Schuldiner et al., 1995; Liu
and Edwards, 1997). Specifically, the uptake of transmitter
involves exchange for lumenal protons, and molecular clon-
ing has now identified three families of proteins responsible
(Reimer et al., 2001). The vesicular GABA transporter
(VGAT)* defined the second of these families with many
members in organisms from yeast to mammals (McIntire et
al., 1997; Sagne et al., 1997).
To identify proteins that might be involved in synaptic
transmission, we focused on one VGAT-related sequence ex-
pressed by astrocytes (Chaudhry et al., 1999). In contrast to
VGAT, this protein localizes to the plasma membrane. How-
ever, heterologous expression of the cDNA did not appear to
confer uptake of potential substrates such as amino acids even
though the only proteins of known function related to
VGAT were a series of amino acid permeases in plants that
included the auxin transporter (Bennett et al., 1996). On the
other hand, VGAT and these plant proteins all use a H
 

 
 elec-
trochemical gradient to drive transport. This coupling mech-
anism suggested the possibility of using proton flux to iden-
tify the substrate: although ionic gradients normally drive the
accumulation of substrate, gradients of substrate can drive
the movement of ions, and this has been used on several oc-
casions to identify the substrate for an orphan transporter
(Pajor and Wright, 1992; Sloan and Mager, 1999). There-
fore, we imaged intracellular pH (pH
 
i
 
) and found that gluta-
mine, histidine, and to a lesser extent asparagine increase the
pH
 
i
 
 of cells expressing the transporter but not of untrans-
fected cells (Chaudhry et al., 1999). The protein thus ex-
changes H
 

 
 for amino acid. In addition, uptake requires ex-
tracellular Na
 

 
. Li
 

 
 also supports uptake, and since Li
 

 
suppresses the background uptake of glutamine by other sys-
tems that do not tolerate Li
 

 
 substitution for Na
 

 
, Li
 

 
 could
also be used to demonstrate glutamine uptake by the protein.
Indeed, the orphan transporter confers Na
 

 
-dependent
transport of glutamine with all the properties described previ-
ously for transport system N (Chaudhry et al., 1999; Gu et
al., 2000), and the proton exchange mechanism accounts for
the pH sensitivity of system N. It is also expressed in the
liver, kidney, and brain, consistent with the original descrip-
tion of system N in the liver (Kilberg et al., 1980). However,
characterization of this system N transporter (SN1) also
showed one feature that was not anticipated.
In the absence of external amino acid substrates, the pH
 
i
 
of cells expressing SN1 (but not untransfected cells) declines
to extremely low levels (
 

 
6.5). This suggests flux reversal
with H
 

 
 uptake coupled to amino acid efflux. Indeed, trans-
fected cells require an external glutamine concentration
 

 
0.4 mM to maintain a pH
 
i
 
 of 
 

 
7.4 (Chaudhry et al.,
1999), indicating that efflux can occur under physiological
conditions. Since most Na
 

 
 cotransporters mediate essen-
tially unidirectional uptake, the flux reversal observed for
SN1 is quite surprising. It may reflect high intracellular glu-
tamine levels, but a typical Na
 

 
-dependent electrogenic
transporter should produce a concentration gradient 
 

 
100-
fold due to the combined driving forces of the Na
 

 
 concen-
tration gradient and resting membrane potential. Regardless
of the mechanism, the efflux of glutamine mediated by SN1
together with its localization to the liver strongly suggests
that it could mediate aspects of the glutamine flux required
for the urea cycle. SN1 may even localize preferentially to
perivenous rather than periportal cells (Gu et al., 2000), sug-
gesting more of a role in glutamine uptake than efflux, but
all hepatocytes appear to express SN1. However, the expres-
sion by astrocytes and not by neurons strongly suggests a
role in the glutamine efflux required for the glutamine–
glutamate cycle involved in replenishing released amino acid
transmitter. In astrocytes, SN1 localizes to the processes that
surround synapses (Chaudhry et al., 1999), and previous
work has shown robust system N activity in cultured astro-
cytes (Nagaraja and Brookes, 1996). In addition, glutamine
and asparagine increase the pH
 
i
 
 of astrocytes with the char-
acteristics expected for SN1 (Chaudhry et al., 2001). An-
other system N transporter (SN2) has been reported recently
to occur in the brain as well, but the cellular pattern of ex-
pression is not known, and the affinity for glutamine is con-
siderably lower than that of SN1 (Nakanishi et al., 2001).
Nonetheless, like SN1, SN2 appears to mediate H
 

 
 ex-
change. In contrast, systems Nm and Nb may not belong to
this family of proteins because Nm and Nb do not show
sensitivity to pH and do not tolerate Li
 

 
 substitution for
Na
 

 
 (Hundal et al., 1987; Tamarappoo et al., 1997).
 
System A is related to system N
 
The known sensitivity of system A to inhibition by low pH
suggested that proteins closely related in sequence to SN1
might encode system A. Indeed, SN1 defines a subfamily of
proteins related to VGAT and several confer neutral amino
acid transport with the properties expected for system A.
One isoform (SAT2, ATA2, or SA1) exhibits almost ubiqui-
tous expression and recognizes other neutral amino acids as
well as or better than glutamine (Reimer et al., 2000; Su-
gawara et al., 2000; Yao et al., 2000). Another (SAT3 or
ATA3) occurs primarily in the liver but recognizes gluta-
mine poorly (Hatanaka et al., 2001). Like classical system A,
all of the SAT isoforms recognize methylated amino acids,
depend on Na
 

 
, tolerate Li
 

 
 substitution, and show sensitiv-
ity to low pH, very similar to SN1. However, a third iso-
form (SAT1, GlnT, ATA1, or SA2) has a more restricted
distribution in the brain (and heart) and preferentially rec-
ognizes glutamine and asparagine as substrates (Varoqui et
al., 2000; Albers et al., 2001; Chaudhry et al., 2002), sug-
gesting a more specific role in glutamine uptake by neurons
required for the glutamine–glutamate cycle. Indeed, SAT1 is
expressed almost exclusively by neurons rather than glia. It
exhibits particularly high levels of expression by inhibitory
neurons, and glutamine affects inhibitory transmission in
 
*Abbreviation used in this paper: VGAT, vesicular GABA transporter.
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the hippocampus at a presynaptic locus (Chaudhry et al.,
2002), consistent with the location of SAT1 at the nerve ter-
minal.
If SN1 and SAT1 exhibit similar functional characteris-
tics, how can they mediate the transfer of glutamine both
out of cells (astrocytes) and into other cells (neurons)? They
differ in one important respect: in contrast to SN1 and 2,
system A transporters SAT1 and -2 do not mediate H
 

 
 flux
(Albers et al., 2001; Chaudhry et al., 2002) (Fig. 2). Their
sensitivity to low pH may thus represent a vestige of the H
 

 
exchange mechanism. In the case of system N, H
 

 
 binding
can result in H
 

 
 translocation but it cannot for system A.
Indeed, low external pH increases the Km of SAT2 and par-
ticularly SAT1 for Na
 

 
, suggesting that H
 

 
 may compete
with Na
 

 
 for binding (Albers et al., 2001; Chaudhry et al.,
2002). Since binding to SAT1 and -2 appears ordered with
Na
 

 
 preceding amino acid, H
 

 
 appear to interfere with the
first binding event (Albers et al., 2001; Chaudhry et al.,
2002). In addition, these observations suggest that the gluta-
mine-gated Na
 

 
/H
 

 
 exchanger SN1 is an evolutionary in-
termediate between VGAT, which mediates only H
 

 
 ex-
change, and the SATs, which mediate only Na
 

 
 cotransport
(Fig. 2). But why would differences in H
 

 
 translocation
confer differences in the direction of glutamine transport by
system N and A transporters?
 
Coupled and uncoupled charge movement
 
Differences in charge movement appear to account for the
different directions of flux mediated by system N and A
transporters. System A proteins all mediate electrogenic
transport due to the uptake of Na
 

 
 and neutral amino acid
unopposed by H
 

 
 (Reimer et al., 2000; Sugawara et al.,
2000; Yao et al., 2000; Albers et al., 2001; Chaudhry et al.,
2002). Although the stoichiometry for Na
 

 
 appears not to
exceed 1, the electrogenic nature of transport by system A
enables membrane potential and Na
 

 
 gradient to provide
the driving force for amino acid uptake (Fig. 2). This should
generate a glutamine concentration gradient 
 

 
100-fold at
resting membrane potential and predicts that SAT1 and -2
will not reverse under physiological conditions.
In contrast to system A transporters, the H
 

 
 exchange me-
diated by SN1 appears to confer electroneutrality by balanc-
ing the Na
 

 
 cotransported with amino acid (Chaudhry et al.,
1999). In this case, membrane potential does not contribute
to the driving force, predicting a much shallower concentra-
 
tion gradient of glutamine (
 

 
12-fold) and flux reversal un-
der physiological conditions (Fig. 1). The high glutamine
concentrations in glia (5–8 mM) may also contribute to ef-
flux (Schousboe et al., 1979; Patel and Hunt, 1985; Storm-
Mathisen et al., 1992). However, we and others have ob-
served currents associated with SN1 expressed in 
 
Xenopus
 
oocytes (Fei et al., 2000; Chaudhry et al., 2001), suggesting
that transport is electrogenic rather than electroneutral. In-
deed, glutamine induces currents with the same properties as
transport by SN1: dependence on Na
 

 
 and sensitivity to low
pH (Fei et al., 2000; Chaudhry et al., 2001). On the other
hand, whereas SAT1 and -2 show fixed charge to amino acid
flux ratios at 
 

 
1 (Chaudhry et al., 2001, 2002), the charge
movement by SN1 can be dissociated from amino acid flux.
In addition, substrates can induce outward charge movement
at positive potentials in oocytes expressing SN1. Further, the
outward charge movement has been observed by multiple
groups and for SN2 and SN1 (Nakanishi et al., 2001). It has
been claimed that only certain substrates can produce these
outward currents, but we have observed them with both glu-
tamine and particularly asparagine in the case of SN1
(Chaudhry et al., 2001). If charge movement were strictly
coupled to transport, it would not be possible for external
amino acid to induce outward currents, strongly suggesting
the existence of an ionic current not stoichiometrically cou-
pled to transport. Ion substitution experiments show that the
conductance is almost entirely selective for H
 

 
 (Chaudhry et
al., 2001). Importantly, the concentration of Na
 

 
 and amino
acid affect the magnitude of these currents, consistent with
gating by the transport cycle, but do not affect their reversal
potential, consistent with the selectivity of the conductance
for H
 

 
. In contrast, external pH affects the magnitude of the
currents and their reversal potential, as anticipated from the
coupling of amino acid transport to H
 

 
 exchange and gating
of the conductance by the transport cycle. Protons thus per-
meate the carrier both coupled to and uncoupled from trans-
port. At positive membrane potentials, glutamine produces
strong alkalinization due to the combined effects of H
 

 
 ex-
change and outward H
 

 
 currents. However, at negative po-
tentials the oocytes alkalinize to a lesser extent because the
uncoupled inward currents carried by H
 

 
 offset the outward
coupled H
 

 
 movement (Chaudhry et al., 2001). In other
words, SN1 can mediate H
 

 
 movement in opposite direc-
tions through coupled and uncoupled mechanisms. This dis-
tinguishes SN1 from many other transporters, which exhibit
Figure 2. Ionic coupling of VGAT, 
system N, and system A transporters. 
VGAT (left) couples the uptake of GABA 
by synaptic vesicles to the movement of 
H down their electrochemical gradient 
(out of vesicles). The positive charge 
inside synaptic vesicles contributes to 
the driving force on H. System N 
transporters (middle) mediate the Na-
dependent uptake of glutamine in 
exchange for H. Electroneutrality 
appears to contribute to the shallow 
amino acid gradients achieved. In contrast, system A transporters (right) mediate only Na cotransport with amino acid. Since amino acid 
substrates are generally neutral, transport is electrogenic, and the resting membrane potential contributes to the driving force on Na, predicting 
the accumulation of amino acid to high concentrations.
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an uncoupled conductance selective for an ion not coupled
to the transport mechanism. For example, plasma membrane
glutamate transporters exhibit a chloride conductance but do
not require chloride for transport (Sonders and Amara,
1996).
Although SN1 exhibits currents uncoupled from trans-
port, this does not indicate that transport is not electrogenic.
However, we have repeatedly found using a variety of differ-
ent substrates and conditions that depolarization does not
inhibit uptake by SN1 (Chaudhry et al., 2001). This may
reflect the electroneutrality of a rate-limiting step in the
transport cycle despite net charge movement, and other
groups have suggested inhibition by depolarization (Fei et
al., 2000), but depolarization does inhibit uptake by the
more clearly electrogenic and closely related SAT1 and -2
(Chaudhry et al., 2002). SN1 thus appears to be electroneu-
tral. On the other hand, substantial evidence indicates coop-
erative activation of SN1 flux by Na
 

 
 (Fei et al., 2000),
suggesting a stoichiometry for Na
 
 
 

 
1. More recently, mea-
surement of flux with 
 
22
 
Na
 

 
 confirmed the uptake of 2–3
Na
 

 
 per amino acid, but transport again did not appear to
involve net charge movement, particularly at low concentra-
tions of substrate (Broer et al., 2002). Since electroneutrality
presumably requires the movement of an equal number of
H
 

 
 in the opposite direction to Na
 

 
, the observations pre-
dict a stoichiometry for H
 

 
 that is also 2–3, and this has not
been assessed. However, even with electroneutrality a stoi-
chiometry for Na
 

 
 of 2–3 predicts very large concentration
gradients of amino acid, inconsistent with the ready flux re-
versal that we and others have observed (Chaudhry et al.,
1999; Broer et al., 2002). Indeed, glutamine concentrates in
oocytes expressing SN1 to an extent consistent with a stoi-
chiometry of 1 Na
 
 
 
rather than 2 (Broer et al., 2002).
Questions thus remain about the basic function of SN1.
Since it is difficult to control the concentration of substrates
and coupled ions in intact cells, reconstitution of the puri-
fied protein in artificial membranes may help to clarify the
ionic coupling. The study of astrocytes will also help to as-
sess the physiological significance of the uncoupled currents.
Nonetheless, H
 

 
 exchange appears to confer the electroneu-
trality of transport required for shallow gradients and the ef-
flux of glutamine from glia. In the liver, SN1 may mediate
both glutamine uptake and release. In contrast, the electro-
genic nature of the SATs presumably confers the unidirec-
tional uptake of glutamine by hepatocytes and neurons.
Interestingly, SAT2 also exhibits an uncoupled Na
 

 
 con-
ductance (Albers et al., 2001; Chaudhry et al., 2002), but
this is detectable only in the absence of substrate, and the
transport-associated currents are entirely coupled.
What is the purpose of the uncoupled conductance associ-
ated with SN1? In addition to conferring electroneutrality,
the coupling to H
 

 
 exchange appears to provide a mecha-
nism for regulation. During synaptic transmission, the pH
 
i
 
of astrocytes increases due to the activation of a Na
 

 
/
HCO3
 

 
 cotransporter (Chesler and Kaila, 1992; Deitmer
and Rose, 1996). This would increase the inward driving
force on H
 

 
 and promote glutamine efflux by SN1, linking
the glutamine–glutamate cycle to the exocytosis of transmit-
ter. Proton coupling may thus confer an important form of
regulation. However, we have also observed that it can cause
 
dramatic swings in pH
 
i
 
. Indeed, H
 

 
 occur at much lower
concentrations (100 nM at pH 7) than either the Na
 

 
 (140
mM) or glutamine (0.5 mM) also translocated by SN1, and
high rates of transport may disturb the pH homeostasis of
cells expressing SN1. The uncoupled H
 

 
 conductance may
therefore serve to short-circuit these pH
 
i
 
 changes and protect
the cell. Interestingly, the conductance appears to be acti-
vated by amino acid uptake rather than efflux, and the nega-
tive resting membrane potential would specifically enable
uncoupled inward H
 

 
 movement to prevent excessive alka-
linization due to coupled H
 

 
 efflux.
 
Future directions
 
Molecular characterization of the system N and A transport-
ers has suggested specific roles in glutamine efflux and up-
take. However, many questions remain about the function
and regulation of these proteins. First, the ionic mechanism
of SN1 remains uncertain: the apparent stoichiometry for
Na
 

 
 still needs to be reconciled with the propensity for flux
reversal. Second, does the uncoupled H
 

 
 conductance occur
in astrocytes, hepatocytes, and oocytes? In addition, several
cells including astrocytes and hepatocytes express both sys-
tem N and A transporters. If one promotes glutamine efflux
and the other uptake, how is their activity coordinated? Per-
haps they are expressed in distinct microdomains on the cell
surface. We also do not understand the mechanisms in-
volved in regulation of these transporters. System A sub-
strates regulate the transcription of SAT genes (Ling et al.,
2001), indicating their role in signaling and metabolism.
However, the mechanism by which transport regulates gene
expression remains unknown. In addition, classical studies
have shown that cell swelling can regulate transport post-
transcriptionally (Bode and Kilberg, 1991), but again the
mechanisms remain to be elucidated. The analysis of system
N and A transporters will also help us to understand the
physiological role of the glutamine–glutamate cycle, particu-
larly in synaptic transmission. How important is the cycle in
transmitter release, and do activities other than system N
and A also have a role? Further, what are the advantages of
this indirect recycling mechanism over direct reuptake by
the nerve terminal? Perhaps the cycle provides greater capac-
ity, speed, and potential for regulation. Genetic and phar-
macologic manipulation in vivo will allow us to test these
possibilities.
Understanding the glutamine–glutamate cycle will in turn
address several biomedical problems. Liver failure produces
encephalopathy, but the mechanism has remained specula-
tive for decades. Interestingly, elevated cerebrospinal fluid
glutamine levels correlate better with the condition than any
other marker (Plum, 1971), suggesting that a disturbance of
the glutamine–glutamate cycle in the liver may result in a
disturbance of the related cycle in the brain. The activation
of system N by cell swelling may also contribute to the brain
edema associated with fulminant hepatic failure. Further,
the pH shifts associated with the glutamine–glutamate cycle
may contribute to the pH changes that accompany spread-
ing depression in migraine.
 
Submitted: 17 January 2002
Revised: 18 March 2002
Accepted: 22 March 2002
 354 The Journal of Cell Biology 
 
|
 
 
 
Volume 157, Number 3, 2002
 
References
 
Albers, A., A. Broer, C.A. Wagner, I. Setiawan, P.A. Lang, E.U. Kranz, F. Lang,
and S. Broer. 2001. Na
 

 
 transport by the neural glutamine transporter
ATA1. 
 
Pflugers Arch. 
 
443:92–101.
Arriza, J.L., S. Eliasof, M.P. Kavanaugh, and S.G. Amara. 1997. Excitatory amino
acid transporter 5, a retinal glutamate transporter coupled to a chloride con-
ductance. 
 
Proc. Natl. Acad. Sci. USA.
 
 94:4155–4160.
Barnett, N.L., D.V. Pow, and S.R. Robinson. 2000. Inhibition of Müller cell glu-
tamine synthetase rapidly impairs the retinal response to light. 
 
Glia.
 
 30:64–
73.
Bender, D.A. 1975. Amino Acid Metabolism. John Wiley & Sons Inc., London.
234 pp.
Bennett, M.J., A. Marchant, H.G. Green, S.T. May, S.P. Ward, P.A. Millner, A.R.
Walker, B. Schulz, and K.A. Feldmann. 1996. Arabidopsis AUX1 gene: a
permease-like regulator of root gravitropism. 
 
Science.
 
 273:948–950.
Bode, B., and M.S. Kilberg. 1991. Amino acid-dependent increase in hepatic sys-
tem N activity is linked to cell swelling. 
 
J. Biol. Chem.
 
 266:7376–7381.
Broer, A., A. Albers, I. Setiawan, R.H. Edwards, F.A. Chaudhry, F. Lang, C.A.
Wagner, and S. Broer. 2002. Regulation of the glutamine transporter SN1
by extracellular pH and intracellular sodium ions. 
 
J. Physiol.
 
 539:3–14.
Chaudhry, F.A., R.J. Reimer, D. Krizaj, D. Barber, J. Storm-Mathisen, D.R.
Copenhagen, and R.H. Edwards. 1999. Molecular analysis of system N sug-
gests novel physiological roles in nitrogen metabolism and synaptic transmis-
sion. 
 
Cell.
 
 99:769–780.
Chaudhry, F.A., D. Krizaj, P. Larsson, R.J. Reimer, C. Wreden, J. Storm-
Mathisen, D. Copenhagen, M. Kavanaugh, and R.H. Edwards. 2001. Cou-
pled and uncoupled proton movement by amino acid transport system N.
 
EMBO J.
 
 20:7041–7051.
Chaudhry, F.A., D. Schmitz, R.J. Reimer, P. Larsson, A.T. Gray, R. Nicoll, M.
Kavanaugh, and R.H. Edwards. 2002. Glutamine uptake by neurons: inter-
action of protons with system A transporters. 
 
J. Neurosci. 22:62–72.
Chesler, M., and K. Kaila. 1992. Modulation of pH by neuronal activity. Trends
Neurosci. 15:396–402.
Chillaron, J., R. Roca, A. Valencia, A. Zorzano, and M. Palacin. 2001. Hetero-
meric amino acid transporters: biochemistry, genetics and physiology. Am. J.
Physiol. Renal Physiol. 281:F995–F1018.
Conti, F., and A. Minelli. 1994. Glutamate immuoreactivity in rat cerebral cortex
is reversibly abolished by 6-diazo-5-oxo-L-norleucine. J. Histochem. Cy-
tochem. 42:717–726.
Dehnes, Y., F.A. Chaudhry, K. Ullensvang, K.P. Lehre, J. Storm-Mathisen, and
N.C. Danbolt. 1998. The glutamate transporter EAAT4 in rat cerebellar
Purkinje cells: a glutamate-gated chloride channel concentrated near the syn-
apse in parts of the dendritic membrane facing astroglia. J. Neurosci. 18:
3606–3619.
Deitmer, J.W., and C.R. Rose. 1996. pH regulation and proton signalling by glial
cells. Prog. Neurobiol. 48:73–103.
Fei, Y.J., M. Sugawara, T. Nakanishi, W. Huang, H. Wang, P.D. Prasad, F.H. Lei-
bach, and V. Ganapathy. 2000. Primary structure, genomic organization,
and functional and electrogenic characteristics of human system N 1, a
Na- and H-coupled glutamine transporter. J. Biol. Chem. 275:23707–
23717.
Giros, B., M. Jaber, S.R. Jones, R.M. Wightman, and M.G. Caron. 1996. Hyper-
locomotion and indifference to cocaine and amphetamine in mice lacking
the dopamine transporter. Nature. 379:606–612.
Gu, S., H. Roderick, P. Camacho, and J.X. Jiang. 2000. Identification and charac-
terization of an amino acid transporter expressed differentially in liver. Proc.
Natl. Acad. Sci. USA. 97:3230–3235.
Gundersen, V., O.P. Ottersen, and J. Storm-Mathisen. 1996. Selective excitatory
amino acid uptake in glutamatergic nerve terminals and in glia in the rat stri-
atum: quantitative electron microscopic immunocytochemistry of exoge-
nous (D)-aspartate and endogenous glutamate and GABA. Eur. J. Neurosci.
8:758–765.
Hamberger, A.C., G.H. Chiang, E.S. Nylen, S.W. Scheff, and C.W. Cotman.
1979. Glutamate as a CNS transmitter. I. Evaluation of glucose and gluta-
mine as precursors for the synthesis of preferentially released glutamate.
Brain Res. 168:513–530.
Handlogten, M.E., E.E. Dudenhausen, W. Yang, and M.S. Kilberg. 1996. Associa-
tion of hepatic system A amino acid transporter with the membrane-cytoskel-
etal proteins ankyrin and fodrin. Biochim. Biophys. Acta. 1282:107–114.
Hatanaka, T., W. Huang, R. Ling, P.D. Prasad, M. Sugawara, F.H. Leibach, and
V. Ganapathy. 2001. Evidence for the transport of neutral as well as cationic
amino acids by ATA3, a novel and liver-specific subtype of amino acid trans-
port system A. Biochim. Biophys. Acta. 1510:10–17.
Haussinger, D. 1990. Nitrogen metabolism in the liver: structural and functional
organization and physiological relevance. Biochem. J. 267:281–290.
Hundal, H.S., M.J. Rennie, and P.W. Watt. 1987. Characteristics of L-glutamine
transport in perfused rat skeletal muscle. J. Physiol. 393:283–305.
Kilberg, M.S., M.E. Handlogten, and H.N. Christensen. 1980. Characteristics of
an amino acid transport system in rat liver for glutamine, asparagine, histi-
dine, and closely related analogs. J. Biol. Chem. 255:4011–4019.
Kvamme, E. 1988. Glutamine and Glutamate in Mammals. CRC Press, Inc., Boca
Raton, Florida. 455 pp.
Laake, J.H., T.A. Slyngstad, F.M. Haug, and O.P. Ottersen. 1995. Glutamine
from glial cells is essential for the maintenance of the nerve terminal pool of
glutamate: immunogold evidence from hippocampal slice cultures. J. Neuro-
chem. 65:871–881.
Ling, R., C.C. Bridges, M. Sugawara, T. Fujita, F.H. Leibach, P.D. Prasad, and V.
Ganapathy. 2001. Involvement of transporter recruitment as well as gene ex-
pression in the substrate-induced adaptive regulation of amino acid trans-
port system A. Biochim. Biophys. Acta. 1512:15–21.
Liu, Y., and R.H. Edwards. 1997. The role of vesicular transport proteins in synap-
tic transmission and neural degeneration. Annu. Rev. Neurosci. 20:125–156.
McGale, E.H., I.F. Pye, C. Stonier, E.C. Hutchinson, and G.M. Aber. 1977. Stud-
ies of the inter-relationship between cerebrospinal fluid and plasma amino
acid concentrations in normal individuals. J. Neurochem. 29:291–297.
McGivan, J.D., and M. Pastor-Anglada. 1994. Regulatory and molecular aspects of
mammalian amino acid transport. Biochem. J. 299:321–334.
McIntire, S.L., R.J. Reimer, K. Schuske, R.H. Edwards, and E.M. Jorgensen.
1997. Identification and characterization of the vesicular GABA transporter.
Nature. 389:870–876.
Nagaraja, T.N., and N. Brookes. 1996. Glutamine transport in mouse cerebral as-
trocytes. J. Neurochem. 66:1665–1674.
Nakanishi, T., R. Kekuda, Y.-J. Fei, T. Hatanaka, M. Sugawara, R.G. Martindale,
F.H. Leibach, P. Prasad, and V. Ganapathy. 2001. Cloning and functional
characterization of a new subtype of the amino acid transport system N. Am.
J. Physiol. Cell Physiol. 281:C1757–C1768.
Oxender, D., and H. Christensen. 1963. Distinct mediating systems for the trans-
port of neutral amino acids by the Ehrlich cell. J. Biol. Chem. 238:3686–
3699.
Pajor, A.M., and E.M. Wright. 1992. Cloning and functional expression of a
mammalian Na/nucleotide cotransporter. A member of the SGLT family.
J. Biol. Chem. 267:3557–3560.
Palacin, M., R. Estevez, J. Bertran, and A. Zorzano. 1998. Molecular biology of the
mammalian plasma membrane amino acid transporters. Physiol. Rev. 78:
969–1054.
Patel, A.J., and A. Hunt. 1985. Concentration of free amino acids in primary cul-
tures of neurones and astrocytes. J. Neurochem. 44:1816–1821.
Plum, F. 1971. The CSF in hepatic encephalopathy. Exp. Biol. Med. 4:34–41.
Pow, D.V., and S.R. Robinson. 1994. Glutamate in some retinal neurons is de-
rived solely from glia. Neuroscience. 60:355–366.
Reimer, R.J., F.A. Chaudhry, A.T. Gray, and R.H. Edwards. 2000. Amino acid
transport System A resembles System N in sequence but differs in mecha-
nism. Proc. Natl. Acad. Sci. USA. 97:7715–7720.
Reimer, R.J., R.T. Fremeau, Jr., E.E. Bellocchio, and R.H. Edwards. 2001. The es-
sence of excitation. Curr. Opin. Cell Biol. 13:417–421.
Rothstein, J.D., and B. Tabakoff. 1984. Alteration of striatal glutamate release after
glutamine synthetase inhibition. J. Neurochem. 43:1438–1446.
Rothstein, J.D., L. Martin, A.I. Levey, M. Dykes-Hoberg, L. Jin, D. Wu, N. Nash,
and R.W. Kuncl. 1994. Localization of neuronal and glial glutamate trans-
porters. Neuron. 13:713–725.
Sagne, C., S. El Mestikawy, M.-F. Isambert, M. Hamon, J.-P. Henry, B. Giros,
and B. Gasnier. 1997. Cloning of a functional vesicular GABA and glycine
transporter by screening of genome databases. FEBS Lett. 417:177–183.
Schousboe, A., L. Hertz, G. Svenneby, and E. Kvamme. 1979. Phosphate activated
glutaminase activity and glutamine uptake in primary cultures of astrocytes.
J. Neurochem. 32:943–950.
Schuldiner, S., A. Shirvan, and M. Linial. 1995. Vesicular neurotransmitter trans-
porters: from bacteria to humans. Physiol. Rev. 75:369–392.
Sloan, J.L., and S. Mager. 1999. Cloning and functional expression of a human
Na() and Cl()-dependent neutral and cationic amino acid transporter
B(0). J. Biol. Chem. 274:23740–23745.
Sonders, S., and S.G. Amara. 1996. Channels in transporters. Curr. Opin. Neuro-
biol. 6:294–302.
Storm-Mathisen, J., N.C. Danbolt, F. Rothe, R. Torp, N. Zhang, J.E. Aas, B.I.
Kanner, I. Langmoen, and O.P. Ottersen. 1992. Ultrastructural immunocy-
Intercellular glutamine transfer | Chaudhry et al. 355
tochemical observations on the localization, metabolism and transport of
glutamate in normal and ischemic brain tissue. Prog. Brain Res. 94:225–241.
Sugawara, M., T. Nakanishi, Y.-J. Fei, H. Huang, M. Ganapathy, F.H. Leibach,
and V. Ganapathy. 2000. Cloning of an amino acid transporter with func-
tional characteristics and tissue expression pattern identical to that of system
A. J. Biol. Chem. 275:16473–16477.
Tamarappoo, B.K., M.K. Raizada, and M.S. Kilberg. 1997. Identification of a sys-
tem N-like Na-dependent glutamine transport activity in rat brain neu-
rons. J. Neurochem. 68:954–960.
Thanki, C.M., D. Sugden, A.J. Thomas, and H.F. Bradford. 1983. In vivo release
from cerebral cortex of [14C]glutamate synthesized from [U-14C]gluta-
mine. J. Neurochem. 41:611–617.
Utsunomiya-Tate, N., H. Endou, and Y. Kanai. 1996. Cloning and functional
characterization of a system ASC-like Na-dependent neutral amino acid
transporter. J. Biol. Chem. 271:14883–14890.
Varoqui, H., H. Zhu, D. Yao, H. Ming, and J.D. Erickson. 2000. Cloning and
functional identification of a neuronal glutamine transporter. J. Biol. Chem.
275:4049–4054.
Verrey, F., C. Meier, G. Rossier, and L.C. Kuhn. 2000. Glycoprotein-associated
amino acid exchangers: broadening the range of transport specificity. Pflugers
Arch. 440:503–512.
Wagner, C.A., F. Lang, and S. Broer. 2001. Function and structure of het-
erodimeric amino acid transporters. Am. J. Physiol. Cell Physiol. 281:C1077–
C1093.
Yao, D., B. Mackenzie, H. Ming, H. Varoqui, H. Zhu, M.A. Hediger, and J.D.
Erickson. 2000. A novel system A isoform mediating Na/neutral amino
acid cotransport. J. Biol. Chem. 275:22790–22797.
356 The Journal of Cell Biology | Volume 157, Number 3, 2002
